Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10093983 Estrogen receptor mutations and uses thereof

Patent 10093983 was granted and assigned to Foundation Medicine on October, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100939830

Patent Inventor Names

Doron Lipson0

Philip James Stephens0

Roman Yelensky0

Vincent A. Miller0

Garrett Michael Frampton0

Gary Palmer0

Jeffrey S. Ross0

Maureen T. Cronin0

Date of Patent

October 9, 2018

Patent Application Number

147533970

Date Filed

June 29, 2015

Patent Citations Received

‌

US Patent 12116638 Estrogen receptor mutations and uses thereof

Patent Primary Examiner

‌

Sean E Aeder

Patent abstract

Novel mutant ESR1 molecules and uses are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10093983 Estrogen receptor mutations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API